James Stanker
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Start not stated–2024-07-15
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Financial Officer | $160,200 | $342,624 |
| 2022 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Financial Officer | $93,875 | $1,040,278 |
| 2021 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Financial Officer | $87,500 | $434,512 |
| 2020 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Financial Officer | $87,500 | $467,552 |
| 2019 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Financial Officer | $87,500 | $250,702 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.